Prostate Cancer: Diagnosis, Clinical Management and Prognosis
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Nephrology & Urology".
Deadline for manuscript submissions: 20 May 2025 | Viewed by 236
Special Issue Editor
Special Issue Information
Dear Colleagues,
The prevalence of prostate cancer (PCa) in Western countries is notably high, increasing with age and making it the second most diagnosed cancer in men. In 2020, approximately 1.4 million new cases and 375,000 deaths were recorded worldwide. In Europe, PCa is the most frequently diagnosed cancer in men and ranks as the third leading cause of cancer-related deaths.
Clinical decision-making and diagnosis for PCa rely on physical examinations, PSA levels, and histopathological evaluations. The highest incidence rates are observed in developed countries, primarily due to increased awareness and the widespread availability of prostate-specific antigen (PSA) screening. While the effectiveness of PSA screening remains a topic of debate, PCa continues to pose a significant public health concern, placing a considerable economic burden on society.
New treatments and therapies for PCa have been developed, with many others currently under evaluation in preclinical and clinical trials. Despite advancements in understanding and managing prostate cancer, knowledge gaps persist.
This Special Issue aims to contribute to the growing body of literature by publishing emerging data, expert opinions, and reviews. It welcomes a broad range of studies related to prostate cancer, encompassing areas such as diagnosis, clinical management, treatment, and prognosis. We encourage the submission of original research, systematic reviews, and meta-analyses.
Thank you for your collaboration.
Prof. Dr. Giovanni Muto
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- prostate cancer
- diagnosis
- clinical management
- prognosis
- treatments
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
